AGILENT TECHNOLOGIES, INC. (A)
Agilent Technologies, Inc. (ticker A) is a diversified technology company headquartered in the United States that designs, manufactures, and markets analytical and diagnostic instruments, software, and services. The company operates primarily in the life sciences and diagnostics sectors, serving research institutions, hospitals, pharmaceutical companies, and industrial laboratories worldwide.
What the company does
Agilent Technologies develops and markets sophisticated analytical instruments and diagnostic systems used in drug discovery, genomics, proteomics, and clinical diagnostics. Its core competencies lie in chromatography, mass spectrometry, spectroscopy, and molecular diagnostics—technologies fundamental to identifying chemical and biological compounds, measuring their properties, and diagnosing diseases.
The company serves a broad customer base including pharmaceutical and biotech firms, academic and government research institutions, hospital laboratories, and industrial manufacturers across chemical, food, environmental, and semiconductor sectors. Agilent’s instruments are typically capital-intensive, precision devices that enable scientists and clinicians to analyze, identify, and quantify substances at the molecular level.
How it makes money
Agilent’s revenue streams comprise both product sales and recurring service revenue. Analytical instruments represent significant capital purchases for labs, generating initial hardware sales. The company derives substantial recurring revenue from consumables—columns, cartridges, reagents, and other supplies that customers must replace regularly. Software and data management solutions also generate licensing and subscription revenue.
The company operates a global sales and service network supporting complex instrumentation deployments. Customer retention depends on technical reliability, application expertise, customer support, and an installed base of compatible consumables and upgrades. Pharmaceutical and biotech customers, representing a material portion of revenue, value continuity and compatibility with established analytical workflows.
Where it sits in its industry
Agilent competes in the fragmented analytical instruments and diagnostics market alongside peers such as Thermo Fisher Scientific, Waters Corporation, and PerkinElmer. The industry is characterized by high barriers to entry—requiring substantial R&D investment, specialized engineering talent, and regulatory compliance capabilities—which creates competitive moats for established players.
The company occupies the middle-to-premium segment of the market, competing on technology sophistication, reliability, and service. Major trends affecting the industry include the rise of molecular diagnostics, the shift toward personalized medicine, increased pharmaceutical development spending, and growing demand for food and environmental testing.
How to research it
Investors and analysts can research Agilent by consulting its regulatory filings with the Securities and Exchange Commission (SEC). The company’s 10-K annual report provides comprehensive detail on business segments, competitive positioning, capital allocation, and management discussion of financial performance. Quarterly 10-Q filings offer updates on operational trends and financial results between fiscal years.
Key sources include the company’s investor relations website, which typically hosts press releases, earnings call transcripts, and presentations to analysts and institutional investors. Industry research firms covering life sciences and diagnostics sectors publish reports on competitive dynamics, market sizing, and technology adoption trends. Scientific and medical journals often reference or evaluate Agilent’s instruments and technologies in research applications, offering third-party perspective on product performance and market adoption.